FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1162393006: Ertugliflozin pidolate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4589173018 Ertugliflozin pidolate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4589174012 Ertugliflozin pidolate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5289360012 Ertugliflozin L-pyroglutamic acid en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ertugliflozin pidolate Is a Sodium glucose cotransporter subtype 2 inhibitor true Inferred relationship Some
Ertugliflozin pidolate Has disposition (attribute) Sodium glucose cotransporter subtype 2 inhibitor (disposition) true Inferred relationship Some
Ertugliflozin pidolate Is modification of (attribute) Ertugliflozin true Inferred relationship Some
Ertugliflozin pidolate Is a Diphenylmethane true Inferred relationship Some
Ertugliflozin pidolate Is a Drug or medicament (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely ertugliflozin (as ertugliflozin pidolate) 15 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Ertugliflozin pidolate Inferred relationship Some 1
Ertugliflozin (as ertugliflozin pidolate) 5 mg oral tablet Has precise active ingredient True Ertugliflozin pidolate Inferred relationship Some 1
Product containing precisely ertugliflozin (as ertugliflozin pidolate) 5 milligram and sitagliptin (as sitagliptin phosphate) 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Ertugliflozin pidolate Inferred relationship Some 2
Product containing precisely ertugliflozin (as ertugliflozin pidolate) 15 milligram and sitagliptin (as sitagliptin phosphate) 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Ertugliflozin pidolate Inferred relationship Some 2

This concept is not in any reference sets

Back to Start